Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
9 april, 14:01
9 april, 14:01
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
PR Newswire
NEW YORK, April 9, 2026
NEW YORK , April 9, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that Lishan Aklog, M.D. , Lucid's Chairman and Chief Executive Officer, will participate in a fireside chat at the 25 th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2026 at 10:15 AM EDT.
The fireside chat will be webcast live and available via the Investor Relations Section of the Lucid Diagnostics website or by clicking here . A replay of the webcast will be archived on the website for 30 days following the live event.
About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard ® Esophageal DNA Test , performed on samples collected in a brief, noninvasive office procedure with its EsoCheck ® Esophageal Cell Collection Device , represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.
For more information, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com .

SOURCE Lucid Diagnostics

9 april, 14:01
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
PR Newswire
NEW YORK, April 9, 2026
NEW YORK , April 9, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.(Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that Lishan Aklog, M.D. , Lucid's Chairman and Chief Executive Officer, will participate in a fireside chat at the 25 th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2026 at 10:15 AM EDT.
The fireside chat will be webcast live and available via the Investor Relations Section of the Lucid Diagnostics website or by clicking here . A replay of the webcast will be archived on the website for 30 days following the live event.
About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard ® Esophageal DNA Test , performed on samples collected in a brief, noninvasive office procedure with its EsoCheck ® Esophageal Cell Collection Device , represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.
For more information, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com .

SOURCE Lucid Diagnostics

Rapporter
Analys
Valet 2026
Rapporter
Analys
Valet 2026
1 DAG %
Senast

OMX Stockholm 30
−0,97%
(vid stängning)
Tomra Systems
Igår, 07:00
Tomra: Kvalitetsbolag i svacka?
Bolåneräntor
25 april, 07:00
Bankerna med lägst bolåneränta
Nordnet
24 april, 17:40
Börsen stängde neråt – ras för Electrolux
Volvo
24 april, 16:15
Analytikern om Volvo: "Marginalen är lite dopad"
OMX Stockholm 30
1 DAG %
Senast
3 101,08